Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Anti-Aging Protocol

OvagenComplete Dosing & Administration Guide

Hepatoprotective tripeptide bioregulator (Glu-Asp-Leu) that penetrates hepatocyte nuclei to bind DNA in the minor groove at AT-rich promoter regions, upregulates antioxidant enzymes (SOD, glutathione peroxidase, GST) beyond melatonin's capacity, and supports liver regeneration through epigenetic activation of hepatocyte proliferation and anti-fibrotic gene programs

Dose Range

10-20mg

Frequency

Multiple times daily

Route

Oral (capsule — standard formulation)

Cycle Length

8-12 weeks

Dosing

How much
do I take?

Starting Dose

1 capsule (10 mg) once daily

Frequency

Once daily

Duration

10 days initial assessment

Conservative oral protocol using the standard capsule formulation. Take 15-30 minutes before meals for optimal absorption. Alternatively, sublingual liquid (5-6 drops, 3-4 times daily) provides faster absorption. Effects are gradual — hepatoprotective gene activation builds over the treatment course. Monitor liver function parameters if available.

Standard Dose

1 capsule (10 mg) twice daily or sublingual 5-6 drops 3-4 times daily

Frequency

Twice daily (capsule) or 3-4 times daily (sublingual)

Duration

10 days per treatment course, 3-4 cycles annually

Standard Khavinson protocol providing a total course dose of 100-200 mg over 10 days. Sublingual formulation provides 0.1 mg peptide/mL with 5-6 drops administered 10-15 minutes before meals. Repeat courses every 3-6 months. Can be combined with Livagen for comprehensive liver bioregulation. Hepatoprotective gene programs activate during the course and persist beyond treatment.

Advanced Dose

10 mg twice daily (oral) or 2-8 mcg/kg subcutaneously

Frequency

Twice daily oral or once daily injectable

Duration

10-30 days per course

Extended protocol for individuals with significant age-related hepatic decline or recovering from liver disease. Injectable route provides more predictable bioavailability. Often combined with Livagen for dual-peptide liver support and Epithalon for comprehensive anti-aging. The 266-person clinical study used peptide courses annually over 6-8 years with cumulative benefits. Medical supervision recommended.

Timing

Best time to take

Take Ovagen at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.

With food?

Ovagen can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.

If stacking

Ovagen should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

  • +You've tolerated the current dose for the recommended period without significant side effects
  • +Therapeutic goals haven't been met at the current dose level
  • +Your healthcare provider recommends dose escalation based on your response
  • +Lab work or clinical assessments support a higher dose

Decrease if

  • -Side effects are bothersome or impacting daily life despite management strategies
  • -You experience any signs of an adverse reaction
  • -Lab results indicate the need for dose reduction
  • -Your healthcare provider recommends a lower dose based on your response

Signs of right dose

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

1
2
3
4

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The weight is on the label

Peptide vial
5mg

Select Weight

mg

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

  • Ovagen in its prescribed form
  • Clean, dry storage container
  • Measuring device if applicable (oral syringe, measuring cup)
  • Calendar or reminder app for dosing schedule

Example

Ovagen comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Use Ovagen exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Injection

Route

Ovagen is administered Oral (capsule — standard formulation)—no injection required

Best sites

  • Not applicable—this is not an injectable formulation

Technique

  • 1.Follow the specific administration instructions for your Ovagen formulation
  • 2.Take or apply as directed by your healthcare provider
  • 3.Store properly between uses according to package instructions
Full Injection Guide

Storage

Before reconstitution

Store Ovagen in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Ovagen should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (twice daily)

As prescribed by your healthcare provider injection

Site: Oral (capsule — standard formulation)—rotate sites if applicable

Maintain a consistent schedule for optimal results with Ovagen. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is it
safe?

Safety Profile

Ovagen demonstrates favorable safety in reproductive endocrinology applications with no serious adverse events reported in clinical ovulation induction studies. As a kisspeptin analog, primary safety consideration is ovarian hyperstimulation syndrome (OHSS) risk, requiring careful hormone monitoring and patient education on abdominal pain, bloating, and nausea symptoms. Mild headaches and injection site reactions occur in <10% of users. Reproductive safety in animal models shows normal fetal development with no teratogenicity.

Clinical trial data from fertility research centers demonstrates kisspeptin's mechanism through GnRH secretion increases (measured via LH/FSH stimulation assays) with more physiologic pulsatile hormone patterns than traditional GnRH agonists. Ultrasound monitoring confirms normal follicle development; estradiol and progesterone levels show physiologic timing patterns. Published outcomes in British Journal of Obstetrics show live birth rates comparable to conventional ovulation induction with improved cycle coordination.

Common Side Effects

Experienced by some users

Mild digestive discomfort

Occasional mild digestive changes during the initial days of oral or sublingual administration, reflecting hepatobiliary function adjustments. Rare occurrence.

Management: Take with a small meal if needed. Typically mild and self-resolving within 2-3 days.

Mild fatigue

Transient fatigue during the adjustment period as hepatic gene programs recalibrate and metabolic function normalizes.

Management: Rest as needed. Usually resolves within 2-3 days. Ensure adequate hydration.

Mild headache

Occasional headache during early treatment, potentially related to hepatic metabolic adjustments.

Management: Ensure adequate hydration. Standard analgesics if needed. Self-limiting.

Minor appetite changes

Slight changes in appetite as liver metabolic function normalizes and hepatic enzyme activity adjusts.

Management: Eat regular balanced meals. Changes are typically modest and temporary.

Less Common

  • Mild nausea

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

  • ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • ×Your healthcare provider recommends discontinuation based on your clinical response
  • ×Development of any new medical condition that may be contraindicated with Ovagen
  • ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • ×Abnormal lab results or clinical markers that suggest adverse effects

Ovagen should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

  • May be used together under medical guidance.
  • May be used together under medical guidance.
  • May be used together under medical guidance.

With medications

  • !Hepatotoxic medications without medical supervision — while Ovagen is hepatoprotective, monitoring is important - Use with caution—discuss with your healthcare provider.
  • !High-dose alcohol — directly counteracts Ovagen's hepatoprotective mechanisms - Use with caution—discuss with your healthcare provider.
  • !Other liver-targeted investigational compounds without medical guidance - Use with caution—discuss with your healthcare provider.

With supplements

  • Multivitamins - Generally safe to take alongside Ovagen. Space doses apart if taking oral formulations to ensure optimal absorption.
  • Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Ovagen research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.

View Full Ovagen Profile

Medical Disclaimer

Ovagen is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: 2/8/2026